Enterprise Value

-8.916M

Cash

25.83M

Avg Qtr Burn

-14.83M

Short % of Float

0.86%

Insider Ownership

15.39%

Institutional Own.

23.26%

Qtr Updated

09/30/22


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Vazalore (325mg and 81mg) Details
Pain reliever / fever reducer; aspirin therapy for vascular indications

Approved

Quarterly sales